Medical devices company Boston Scientific is to invest €26m in research and development at its Clonmel facility. IDA Ireland is supporting the investment.
The investment is linked to the design of the company's next-generation cardiac rhythm management devices, which are manufactured at the Clonmel facility.
Boston Scientific set up operations in Ireland in 1994 and is one of the country's largest employers, with facilities in Clonmel, Galway and Cork.
'This investment is great news for Clonmel, and we must seize this opportunity to ensure that investments like this can be replicated across the country to create jobs and get the economy growing again,' said Jobs, Enterprise & Innovation Minister Richard Bruton.
'I am confident that, with the talent and expertise of our Clonmel staff, we can continue to successfully commercialise new life-saving innovations for our customers and their patients worldwide,' said Brad Sorenson, vice president of operations for Boston Scientific.
